research use only
Cat.No.S7699
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other Ferroptosis Inhibitors | Erastin Ferrostatin-1 (Fer-1) Imidazole Ketone Erastin (IKE) FIN56 UAMC-3203 SRS11-92 SRS16-86 icFSP1 N6F11 Bufotalin |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| MRC-5 lung fibroblast cells | DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells, IC50 = 9.14 μM | ChEMBL | ||||
| Click to View More Cell Line Experimental Data | ||||||
| Molecular Weight | 340.85 | Formula | C19H21ClN4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 950455-15-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CNCCC12C(=NCC3=CC(=CC=C3)Cl)NC4=CC=CC=C4N2 | ||
|
In vitro |
DMSO
: 68 mg/mL
(199.5 mM)
Ethanol : 18 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
ferroptosis
(Cell-free assay) 22 nM
|
|---|---|
| In vitro |
Liproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of Gpx4−/−cells with IC50 of 22 nM. This compound (50 nM) completely prevents lipid peroxidation in Gpx4−/−cells. It (200 nM) protects against FINs, such as BSO (10 µM), erastin (1 µM) and RSL3 (0.5 µM), in a dose dependent manner, whereas it fails to rescue cell death induced by staurosporine (0.2 µM) and H2O2 (200 µM).
|
| In vivo |
Liproxstatin-1 remarkably extends survival compared with the vehicle-treated group, delays Ferroptosis in tubular cells, and mitigates tissue injury in ischaemia/reperfusion-induced liver injury.
|
References |
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | COX2 / GPx4 / GAPDH β-actin / COX2 / GPx4 β-actin / COX2 / GPx4 NeuN / Syn / SNAP / GFAP / Actin / Tubulin GRP78 / CHOP / Actin GRP78 / CHOP / Actin GPX4 / β-actin |
|
33889074 |
| Growth inhibition assay | Cell viability |
|
31641008 |
| Immunofluorescence | β-actin / COX2 / GPx4 NeuN / ACSL4 mitochondrial Fe2+ |
|
30737476 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.